Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer
Conditions: Colon Cancer Interventions: Drug: Doublet or triplet chemotherapy combined with cetuximab Sponsors: Qilu Hospital of Shandong University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Erbitux | Hospitals | Liver | Research | Urology & Nephrology